Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Alcohol / Addiction / Illegal Drugs News
The Association Of Alcohol Drinking With Migraine Headache Migraine is a neurovascular disease that affects about 15% of the western population. Compounds in foods and beverages (chocolate, wine, citrus, etc) considered as migraine triggers include tyramine, phenylethylamine and possibly histamine and phenolic compounds.	13 June 2011
Preventing Avoidable Opioid-Related Deaths Top Priority For Pain Medicine Field Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.	13 June 2011
Health Data Can Help Address Alcohol-Related Harm In Youth Administrative information can be useful for surveillance and understanding of alcohol-related harm in young people, states an article in CMAJ (Canadian Medical Association Journal). Binge drinking and overconsumption of alcohol by young people is a growing issue in many countries.	13 June 2011
High Rates Of Injection Drug Use In Urban Aboriginal Youth Signal Need For Prevention Programs A new study indicates high rates of injection drug use in urban Canadian Aboriginal youth, particularly in women, and points to the need for culturally specific prevention programs, states an article in CMAJ (Canadian Medical Association Journal).	13 June 2011

Alzheimer's / Dementia News

Dietary Changes Appear To Affect Levels Of Biomarkers Associated With Alzheimer's Disease Following a low-saturated fat and low-glycemic index diet appears to modulate the risk of developing dementia that proceeds to Alzheimer's disease (AD), although making a switch to this dietary pattern may not protect those already experiencing cognitive difficulty, according to a report in the June issue of Archives of Neurology, one of theJAMA/Archives journals.

13 June 2011

Arthritis / Rheumatology News
LFA Represents Lupus Community At Pediatric Rheumatic Drug Treatment Meeting Today, Sandra C. Raymond, President and CEO of Lupus Foundation of America, will be representing the lupus advocacy community at a meeting of key stakeholders from the federal government, industry, and academia where they will be discussing pediatric rheumatic drug treatments and a consolidated adverse events registry.	13 June 2011

Autism News
Routine Autism Screening Not Necessary, Say Canadian Researchers Researchers from McMaster University believe that routine autism screening for all children is not necessary. They say that "there is not enough sound evidence supporting the implementation of a routine population-based screening program for autism.	13 June 2011
McMaster Researchers Say Routine Screening For Autism Not Needed Proposals recommending routine screening of all children for autism gets a thumbs down from researchers at McMaster University.In a study in the online edition of the journal Pediatrics, the researchers say there is "not enough sound evidence to support the implementation of a routine population-based screening program for autism.	13 June 2011

Headache / Migraine News
The Association Of Alcohol Drinking With Migraine Headache Migraine is a neurovascular disease that affects about 15% of the western population. Compounds in foods and beverages (chocolate, wine, citrus, etc) considered as migraine triggers include tyramine, phenylethylamine and possibly histamine and phenolic compounds.	13 June 2011

Heart Disease News
Baxter Introduces First Ready-to-Use IV Amiodarone Baxter International Inc. (NYSE:BAX) announced today at the American Society of Health-System Pharmacists Summer Meeting and Exhibition that it has launched NEXTERONE® (amiodarone HCl) Premixed Injection, the first and only ready-to-use premixed intravenous (IV) bag version of the antiarrhythmic agent amiodarone in the United States.	13 June 2011
GE Healthcare And Rapidscan Pharma Solutions EU Ltd Announce The Launch Of Rapiscan® (Regadenoson) In The United Kingdom Today GE Healthcare and Rapidscan Pharma Solutions EU Ltd report the launch of Rapiscan® (regadenoson) in the United Kingdom, the first country in Europe to have access. Rapiscan is a new generation pharmacological stress agent for myocardial perfusion scintigraphy (MPS) in adult patients unable to undergo adequate exercise stress in the diagnosis of coronary artery disease (CAD)1 - the single most common cause of death and disability in Europe.	13 June 2011

IT / Internet / E-mail News
Scientists Pioneer Way To Find More Chromosomal Aberrations In Tumors; Results Likely To Advance Understanding Of Cancer A dramatically better computer tool for finding the genetic missteps that fuel cancer has been developed by St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project investigators.	13 June 2011

Mental Health News
Innovative £1.9 Million Partnership To End Mental Health Discrimination In Wales Three leading mental health charities in Wales are granted nearly £2 million for collaboration and joining forces today to challenge the stigma and discrimination surrounding mental health problems with the launch of a new national programme.	13 June 2011

Pharmacy / Pharmacist News
Federal Government Takes Action Against Drug Manufacturer And Distributor The U.S. Food and Drug Administration announced today that a consent decree of condemnation, forfeiture, and permanent injunction has been filed against H&P Industries Inc., The Triad Group Inc.	13 June 2011
Valeant And GlaxoSmithKline Announce U.S. FDA Approval Of Potiga(TM) (Ezogabine) Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga(TM) (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.	13 June 2011
FDA Approves Redesigned Labels For Some Merck Drugs The U.S. Food and Drug Administration today is announcing the approval of Merck's redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation.	13 June 2011
Studies Evaluate Criteria For Detecting Potentially Inappropriate Medications In Older Hospitalized Patients Using the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) criteria was associated with identification of adverse drug events in older patients, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals.	13 June 2011
Article Outlines Principles For A Conservative Approach To Prescribing Medication A shift toward more conservative medication-prescribing practices would serve patients better, according to a review article published Online First today by Archives of Internal Medicine, one of the JAMA/Archives journals.	13 June 2011

Seniors / Aging News
Reducing Avoidable Rehospitalizations Among Seniors The rehospitalization of senior patients within 30 days of discharge from a skilled nursing facility (SNF) has risen dramatically in recent years, at an estimated annual cost of more than $17 billion.	13 June 2011
Studies Evaluate Criteria For Detecting Potentially Inappropriate Medications In Older Hospitalized Patients Using the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) criteria was associated with identification of adverse drug events in older patients, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals.	13 June 2011
Ranibizumab Likely Linked To Better Age-Related Macular Degeneration Outcomes Ranibizumab has potential to prevent blindness and visual impairment from age-related macular degeneration in non-Hispanic Caucasian patients, according to a computer-modeling study carried out by scientists at the Wilmer Eye Institute, The Johns Hopkins University, Baltimore.	13 June 2011

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .